Cytophage Technologies (TSXV:CYTO) Other Stockholders Equity : C$-0.00 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Other Stockholders Equity?

Cytophage Technologies's Other Stockholders Equity for the quarter that ended in Mar. 2024 was C$-0.00 Mil.

Cytophage Technologies's quarterly Other Stockholders Equity increased from Sep. 2023 (C$0.00 Mil) to Dec. 2023 (C$1.15 Mil) but then declined from Dec. 2023 (C$1.15 Mil) to Mar. 2024 (C$-0.00 Mil).

Cytophage Technologies's annual Other Stockholders Equity declined from Dec. 2021 (C$0.00 Mil) to Dec. 2022 (C$-0.00 Mil) but then increased from Dec. 2022 (C$-0.00 Mil) to Dec. 2023 (C$1.15 Mil).

Cytophage Technologies Other Stockholders Equity Historical Data

The historical data trend for Cytophage Technologies's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Other Stockholders Equity Chart

Cytophage Technologies Annual Data

Trend

Dec21

Dec22

Dec23

Other Stockholders Equity

1.15

Cytophage Technologies Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Other Stockholders Equity	Get a 7-Day Free Trial			-	-	-	1.15	-

Cytophage Technologies Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Cytophage Technologies Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytophage Technologies (TSXV:CYTO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.